Clinical Trial Update: Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102) [Phase 3]

View source ↗

Summary

Organon announced the completion of a Phase 3 trial evaluating tapinarof for atopic dermatitis in children and adults, with results posted on 2025-09-02.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tapinarof (tapinarof)

Snippet

Sponsor: Organon and Co | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2025-09-02